American Supply Association members urge Congress to make beneficial changes to the Paycheck Protection Program
June 04, 2020 10:29 ET
|
American Supply Association
ITASCA, Illinois, June 04, 2020 (GLOBE NEWSWIRE) -- Note: ASA Director of Government Affairs Steve Rossi is available for interviews on this subject. The American Supply Association, whose...
Amid the COVID-19 crisis and the looming economic recession, the Energy based Ablation Devices market worldwide will grow by a projected US$4.6 Billion, during the analysis period
May 27, 2020 11:58 ET
|
ReportLinker
New York, May 27, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Energy based Ablation Devices Industry" -...
Amid the COVID-19 crisis and the looming economic recession, the Energy based Ablation Devices market worldwide will grow by a projected US$4.6 Billion, during the analysis period
May 26, 2020 17:32 ET
|
ReportLinker
New York, May 26, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Energy based Ablation Devices Industry" -...
Trevena Announces Presentations at the American Society of Anesthesiologists 2019 Annual Meeting
October 21, 2019 10:30 ET
|
Trevena Inc.
CHESTERBROOK, Pa., Oct. 21, 2019 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with...
TLC Presents Clinical and Preclinical Data of TLC590 at ANESTHESIOLOGY® Annual Meeting and in International Journal of Nanomedicine
October 21, 2019 05:24 ET
|
TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Oct. 21, 2019 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...
Soleno Therapeutics Announces Appointment of Industry Veteran Gwen A. Melincoff to Board of Directors
April 29, 2019 08:00 ET
|
Soleno Therapeutics
REDWOOD CITY, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the...
Photocure ASA: Daniel Schneider appointed Chief Executive Officer
September 20, 2018 02:30 ET
|
Photocure ASA
Oslo, Norway, 20 September 2018: Photocure ASA (OSE: PHO), announces today that Daniel Schneider has been appointed President and Chief Executive Officer of Photocure. Mr Schneider joins Photocure...
Photocure ASA: Mandatory notification of trade
September 03, 2018 02:17 ET
|
Photocure ASA
Oslo, Norway, 3 September 2018: Photocure ASA (OSE: PHO), announces today that it has repurchased 1,121 own shares at NOK 0 per share in relation to the long-term incentive programme described in...
Photocure ASA: Exclusive Nordic distribution agreement for innovative drug delivery system for bladder cancer patients
August 27, 2018 01:53 ET
|
Photocure ASA
Oslo, Norway, August 27, 2018: Photocure ASA, The Bladder Cancer Company, announces today that an exclusive distribution agreement for the Nordic area for an innovative and patented medical device...
Photocure ASA: Results for the second quarter of 2018
August 08, 2018 01:25 ET
|
Photocure ASA
Oslo, Norway, 8 August 2018: Photocure ASA (OSE:PHO), today reported a revenue growth of 56% in local currency for the U.S. market in the second quarter of 2018, contributing to Hexvix/Cysview...